ArticleMethods in molecular biology (Clifton, N.J.)2025
In Vitro Maturation and Time-Lapse Imaging of Immature Human Oocytes: A Direction Toward Clinical Applications.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recently, multiple teams reported the successful utilization of denuded oocytes matured in vitro after controlled ovarian stimulation, as well as their small but significant contribution to cumulative live-birth rates after intracytoplasmic sperm injection (ICSI). Published data are in favor of rescue ICSI when mature oocytes are obtained one day after oocyte pickup, the clinical contribution being higher for patient with advanced maternal age, low ovarian response to COS, low maturation rate, or low fertilization rate. From a strictly resource-oriented perspective, rescue ICSI of immature oocytes may not be cost-effective as it would require additional expenses related to consumables, media, and embryologist time and as the developmental potential of such oocytes is consistently decreased across reported studies compared to their sibling mature oocytes. Being able to select the right clinical context as well as the right oocytes to fertilize to optimize outcome and resources spent is thus of significant clinical value. In that regard, even if more costly than conventional culture, time-lapse imaging may play an important role as morphokinetic markers of oocyte maturation and oocyte developmental potential have been described. However, the limited number of reported cases warrants for the restricted use of rescue ICSI only in registered clinical trials with long-term follow-up of children obtained from this still experimental procedure.
Indexed as
Identifiers
40736789What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.